Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Debt Ratio (2016 - 2017)

Bone Biologics has reported Debt Ratio over the past 3 years, most recently at 10.34 for Q4 2017.

  • Quarterly Debt Ratio fell 17.24% to 10.34 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 10.34 through Dec 2017, down 17.24% year-over-year, with the annual reading at 10.34 for FY2017, 17.24% down from the prior year.
  • Debt Ratio was 10.34 for Q4 2017 at Bone Biologics, down from 12.05 in the prior quarter.
  • Over five years, Debt Ratio peaked at 21.98 in Q2 2017 and troughed at 3.32 in Q1 2016.
  • The 3-year median for Debt Ratio is 11.09 (2017), against an average of 11.28.
  • The largest YoY upside for Debt Ratio was 250.2% in 2017 against a maximum downside of 37.89% in 2017.
  • A 3-year view of Debt Ratio shows it stood at 4.58 in 2015, then surged by 172.96% to 12.5 in 2016, then fell by 17.24% to 10.34 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Debt Ratio are 10.34 (Q4 2017), 12.05 (Q3 2017), and 21.98 (Q2 2017).